Why has the prevalence of maintenance therapy for acute lymphoblastic leukemia (ALL) declined?

Updated: Jun 20, 2019
  • Author: Karen Seiter, MD; Chief Editor: Emmanuel C Besa, MD  more...
  • Print
Answer

The percentage of patients who complete consolidation and maintenance therapy has declined recently as more patients are referred for transplant while they are in first remission. The frequency of transplant has increased with the use of alternative donors (unrelated, cord blood, and haploidentical), which make it unlikely that a patient will not be able to find a donor.


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!